Seraphina Therapeutics, Inc.
PrivateLast Round
Series A
Extension
Oct 13, 2021
Total Funding Raised
$11.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Seraphina Therapeutics, Inc. is a health and wellness company that develops evidence-driven consumer health products, including fatty acid supplements and nutritional interventions, focused on healthy aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Sports & Fitness
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seraphina Therapeutics, Inc. Comparables
Compare Seraphina Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elysium Health | 84% | |
| DoNotAge | 79% | |
| NOVOS | 78% |
Seraphina Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 13, 2021 | ||||
| Series A | May 18, 2020 |
Key People
Founding team and executive leadership
Seraphina Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Domain Associates | Series A Extension, Series A |
| Cue Ball | Series A Extension |
| BioBrit | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 161% MoM, reaching 5.4K.
- Jun 20, 2026
Monthly visitors increased 61% MoM.
Seraphina Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Seraphina Therapeutics, Inc.'s valuation, stock price, and market status.
Is Seraphina Therapeutics, Inc. a public or private company?
Seraphina Therapeutics, Inc. is a private company.
What is the current stock price of Seraphina Therapeutics, Inc.?
Seraphina Therapeutics, Inc. is a private company with no public stock price. Caplight tracks Seraphina Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Seraphina Therapeutics, Inc. worth (valuation)?
Valuation information for Seraphina Therapeutics, Inc. is not publicly available.
Can I buy Seraphina Therapeutics, Inc. stock?
Seraphina Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Seraphina Therapeutics, Inc.'s last funding round?
Seraphina Therapeutics, Inc.'s most recent funding round was Series A Extension on October 13, 2021.
Who are the main investors in Seraphina Therapeutics, Inc.?
Key investors in Seraphina Therapeutics, Inc. include Domain Associates, Cue Ball.
Will Seraphina Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Seraphina Therapeutics, Inc..
How can I track Seraphina Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Seraphina Therapeutics, Inc.'s secondary market activity and sign up for updates.